FIELD: pharmacology.
SUBSTANCE: invention is a method for treatment of papulopustular rosacea in a subject in need thereof, comprising topical application of a therapeutically effective amount of a pharmaceutical composition comprising ivermectin and a pharmaceutically acceptable carrier, once a day, to a region of skin afflicted with papulopustular rosacea, wherein the treatment results in a significant reduction in the number of inflammatory foci within 2 weeks after the initial application of the pharmaceutical composition.
EFFECT: significant reduction in the number of inflammatory foci two weeks after the initial application without joint application of another active agent, more effective treatment, and a longer remission, a reduction in adverse skin reactions.
16 cl, 12 dwg, 7 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF INFLAMMATORY DAMAGES IN CASE OF ROSAZEA USING IVERMECTIN | 2014 |
|
RU2633481C2 |
| METHOD FOR COMBINATION THERAPY OF ROSACEA | 2021 |
|
RU2806053C2 |
| COMPOSITIONS AND USE THEREOF FOR TREATING OR PREVENTING ROSACEA | 2017 |
|
RU2738932C2 |
| METHOD OF COMPLEX EXTRINSIC FOR PATIENTS WITH ERITHEMATOUS PAPULAR ROSACEA | 2017 |
|
RU2645932C1 |
| METHOD OF TREATMENT OF ROSACEA | 2020 |
|
RU2811956C2 |
| THERAPEUTIC REGIMEN FOR ACNE-RELATED DISEASES | 2009 |
|
RU2490035C2 |
| METHOD OF LOCAL TREATMENT OF FACIAL PAPULOPUSTULAR DERMATOSES | 2022 |
|
RU2790768C1 |
| COMPOSITIONS CONTAINING BERBERINE OR ITS ANALOGUES FOR TREATING SKIN DISEASES RELATED TO ROSACEA OR BLUSH | 2010 |
|
RU2533458C2 |
| COMPOSITIONS CONTAINING BERBERINE OR ANALOGS THEREOF FOR TREATING ROSACEA OR RED FACE RELATED SKIN DISORDERS | 2014 |
|
RU2671492C2 |
| METHOD OF ANTIOXIDANT STATUS CORRECTION IN TREATING ERYTHEMATOUS-TELANGIECTATIC AND PAPULOPUSTULAR FORMS OF ROSACEA OF MILD AND MODERATE SEVERITY | 2020 |
|
RU2741988C1 |
